Anti-osteoporotic effect of Gengnian Jianshen decoction in rats
Purpose: To investigate the therapeutic effect and mechanism of action of Gengnian Jianshen Decoction (GJD) on ovariectomy-induced osteoporosis in rats.
Methods: Female Sprague-Dawley rats were randomly assigned to a sham-operated group (control), and five ovariectomy (OVX) sub-groups, that is, OVX with vehicle (OVX), OVX with Xianling Gubao capsule (positive control drug, 120 mg/kg/day), and OVX with GJD doses (70, 140, and 280 mg/kg/day). The treatments were given orally daily for 16 weeks (starting 4 weeks after the rats were subjected to ovariectomy. Bone mineral density (BMD) of the L4 vertebrae and right femur of each rat was estimated. Serum levels of estradiol (E2), follicle-stimulating hormone (FSH) and luteinizing hormone (LH), as well as interleukin-6 (IL-6) and insulin-like growth factor 1(IGF-1) of rats in all the groups were determined using ELISA.
Results: The results showed that GJD dose-dependently inhibited BMD reduction in L4 vertebrae and femur, and significantly increased serum E2, FSH and LH levels (p < 0.05) in the osteoporotic rats. Moreover, GJD significantly decreased serum IL-6 levels and increased levels of IGF-1 (p < 0.05).
Conclusion: These findings indicate that GJD prevents OVX-induced osteoporosis in rats without hyperplastic effects on the uterus. Thus, GJD has potential for use in the treatment of post-menopausal osteoporosis.
Keywords: Gengnian Jianshen decoction, Osteoporosis, Ovariectomy, Bone mineral density
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.